374
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Combination of the CAGE and serum gamma-glutamyl transferase: an effective screening tool for alcohol use disorder and alcohol dependence

, , , , &
Pages 1507-1515 | Published online: 31 May 2019

References

  • Crombie IK, Irvine L, Elliott L, Wallace H. How do public health policies tackle alcohol-related harm: a review of 12 developed countries. Alcohol Alcohol. 2007;42(5):492–499. doi:10.1093/alcalc/agl08317341517
  • Bradley KA, Donovan DM, Larson EB. How much is too much? Advising patients about safe levels of alcohol consumption. Arch Intern Med. 1993;153(24):2734–2740. doi:10.1001/archinte.1993.004102400360048257248
  • Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804. doi:10.1111/add.1993.88.issue-68329970
  • Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995;56(4):423–432.7674678
  • Piccinelli M, Tessari E, Bortolomasi M, et al. Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study. Bmj. 1997;314(7078):420–424. doi:10.1136/bmj.314.7078.4209040389
  • Clements R. A critical evaluation of several alcohol screening instruments using the CIDI-SAM as a criterion measure. Alcohol Clin Exp Res. 1998;22(5):985–993. doi:10.1111/j.1530-0277.1998.tb03693.x9726267
  • Allen JP, Litten RZ, Fertig JB, Babor T. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res. 1997;21(4):613–619.9194913
  • Ewing JA. Detecting alcoholism. The CAGE questionnaire. Jama. 1984;252(14):1905–1907. doi:10.1001/jama.1984.033501400510256471323
  • Knight JR, Sherritt L, Harris SK, Gates EC, Chang G. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcohol Clin Exp Res. 2003;27(1):67–73. doi:10.1097/01.ALC.0000057944.57330.6512544008
  • Adams WL, Barry KL, Fleming MF. Screening for problem drinking in older primary care patients. Jama. 1996;276(24):1964–1967. doi:10.1001/jama.1996.035402400420288971065
  • Fiellin DA, Reid MC, O’Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000;160(13):1977–1989. doi:10.1001/archinte.160.13.197710888972
  • Freeman WM, Vrana KE. Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders. Alcohol Clin Exp Res. 2010;34(6):946–954. doi:10.1111/j.1530-0277.2010.01169.x20374220
  • Frank D, DeBenedetti AF, Volk RJ, Williams EC, Kivlahan DR, Bradley KA. Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic groups. J Gen Intern Med. 2008;23(6):781–787. doi:10.1007/s11606-008-0594-018421511
  • Steinweg DL, Alcoholism WH. the keys to the CAGE. Am J Med. 1993;94(5):520–523. doi:10.1016/0002-9343(93)90088-78498397
  • Liangpunsakul S, Qi R, Crabb DW, Witzmann F. Relationship between alcohol drinking and aspartate aminotransferase:alanine aminotransferase (AST:ALT) ratio, mean corpuscular volume (MCV), gamma-glutamyl transpeptidase (GGT), and apolipoprotein A1 and B in the U.S. population. J Stud Alcohol Drugs. 2010;71(2):249–252. doi:10.15288/jsad.2010.71.24920230722
  • Peterson K. Biomarkers for alcohol use and abuse–a summary. Alcohol Res Health. 2004;28(1):30–37.19006989
  • Conigrave KM, Davies P, Haber P, Whitfield JB. Traditional markers of excessive alcohol use. Addiction. 2003;98(Suppl 2):31–43. doi:10.1046/j.1359-6357.2003.00581.x14984240
  • Coulton S, Drummond C, James D, et al. Opportunistic screening for alcohol use disorders in primary care: comparative study. Bmj. 2006;332(7540):511–517. doi:10.1136/bmj.38743.421574.7C16488896
  • American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed ed. Washington, DC: American Psychiatric Association; 1994.
  • National Institute on Alcohol Abuse and Alcoholism (U.S.). The Physicians’ Guide to Helping Patients with Alcohol Problems. [Rockville, Md.]: U.S. Dept. of Health and Human Services,Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; 1995.
  • Friedmann PD, Saitz R, Gogineni A, Zhang JX, Stein MD. Validation of the screening strategy in the NIAAA “Physicians’ guide to helping patients with alcohol problems”. J Stud Alcohol. 2001;62(2):234–238. doi:10.15288/jsa.2001.62.23411332444
  • Bradley KA, Bush KR, McDonell MB, Malone T, Fihn SD. Screening for problem drinking: comparison of CAGE and AUDIT. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. J Gen Intern Med. 1998;13(6):379–388. doi:10.1046/j.1525-1497.1998.00118.x
  • Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT: The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Care. Geneva, Switzerland: World Health Organization; 2001.
  • JS OM K, Park BK, Lee MK, Kim GJ. Screening criteria of alcoholism by alcohol use disorders identification test(AUDIT) in Korea. J Korean Acad Fam Med. 1999;20(9):1152–1159.
  • BK LD P, Lee TY, Cho YC, Kwon YH. Comparison of screening tests for alcoholism in terms of reliability, sensitivity and specificity. Chungnam Med J. 2000;27:37–47.
  • Szasz G. New substrates for measuring gamma-glutamyl transpeptidase activity. Z Klin Chem Klin Biochem. 1974;12(5):228.
  • Persijn JP, van der Slik W. A new method for the determination of gamma-glutamyltransferase in serum. J Clin Chem Clin Biochem. 1976;14(9):421–427.9466
  • Mackinnon A, Mulligan R. Combining cognitive testing and informant report to increase accuracy in screening for dementia. Am J Psychiatry. 1998;155(11):1529–1535. doi:10.1176/ajp.155.11.15299812113
  • Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839–843. doi:10.1148/radiology.148.3.68787086878708
  • Liangpunsakul S, Lai X, Ross RA, et al. Novel serum biomarkers for detection of excessive alcohol use. Alcohol Clin Exp Res. 2015;39(3):556–565. doi:10.1111/acer.1265425704570
  • Do Amaral RA, Malbergier A. Effectiveness of the CAGE questionnaire, gamma-glutamyltransferase and mean corpuscular volume of red blood cells as markers for alcohol-related problems in the workplace. Addict Behav. 2008;33(6):772–781. doi:10.1016/j.addbeh.2007.12.00618337017
  • Hermansson U, Helander A, Huss A, Brandt L, Ronnberg S. The Alcohol Use Disorders Identification Test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace health examination. Alcohol Clin Exp Res. 2000;24(2):180–187. doi:10.1111/j.1530-0277.2000.tb04589.x10698370
  • Harasymiw J, Bean P. The combined use of the early detection of alcohol consumption (EDAC) test and carbohydrate-deficient transferrin to identify heavy drinking behaviour in males. Alcohol Alcohol. 2001;36(4):349–353. doi:10.1093/alcalc/36.4.34911468138
  • Dolman JM, Hawkes ND. Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients. Alcohol Alcohol. 2005;40(6):515–519. doi:10.1093/alcalc/agh18916103035
  • Bataille V, Ruidavets JB, Arveiler D, et al. Joint use of clinical parameters, biological markers and CAGE questionnaire for the identification of heavy drinkers in a large population-based sample. Alcohol Alcohol. 2003;38(2):121–127. doi:10.1093/alcalc/agg05112634258
  • Golka K, Sondermann R, Reich SE, Wiese A. Carbohydrate-deficient transferrin (CDT) as a biomarker in persons suspected of alcohol abuse. Toxicol Lett. 2004;151(1):235–241. doi:10.1016/j.toxlet.2004.01.02315177658
  • Reynaud M, Schellenberg F, Loisequx-Meunier MN, et al. Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV). Alcohol Clin Exp Res. 2000;24(9):1414–1419.11003208
  • Bortolotti F, De Paoli G, Tagliaro F. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;841(1–2):96–109. doi:10.1016/j.jchromb.2006.05.005
  • Sillanaukee P, Olsson U. Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gamma-glutamyltransferase. Clin Chem. 2001;47(4):681–685.11274018
  • Viel G, Boscolo-Berto R, Cecchetto G, Fais P, Nalesso A, Ferrara SD. Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis. Int J Mol Sci. 2012;13(11):14788–14812. doi:10.3390/ijms13111478823203094
  • Hastedt M, Buchner M, Rothe M, et al. Detecting alcohol abuse: traditional blood alcohol markers compared to ethyl glucuronide (EtG) and fatty acid ethyl esters (FAEEs) measurement in hair. Forensic Sci Med Pathol. 2013;9(4):471–477. doi:10.1007/s12024-013-9416-823504201
  • Tynjala J, Kangastupa P, Laatikainen T, Aalto M, Niemela O. Effect of age and gender on the relationship between alcohol consumption and serum GGT: time to recalibrate goals for normal ranges. Alcohol Alcohol. 2012;47(5):558–562. doi:10.1093/alcalc/ags07222753786
  • Mihas AA, Tavassoli M. Laboratory markers of ethanol intake and abuse: a critical appraisal. Am J Med Sci. 1992;303(6):415–428. doi:10.1097/00000441-199206000-000141605174